The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications.

BOSTON—Clinicians may want to rethink the antibiotics they prescribe for vancomycin-resistant Enterococcus (VRE) urinary tract infections (UTIs). A new retrospective study presented at the 50 th ...

A new study finds that two subtypes of pathogenic Escherichia coli (E. coli) produce five to 16 times more protective capsular 'slime' when Enterococcus faecalis (EF) is present. The finding could ...

The incidence of enterococcal infections has been increasing over the past few years, with rising rates of multidrug resistance. VRE is increasingly a problem in many hospitals and intensive care ...